Jeff Yass’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Buy
+36,736
New +$1.13M ﹤0.01% 7836
2026
Q1
Sell
-12,578
Closed -$356K 13948
2025
Q4
$356K Buy
+12,578
New +$355K ﹤0.01% 9550
2024
Q3
Sell
-9,176
Closed -$214K 12865
2024
Q2
$214K Buy
+9,176
New +$214K ﹤0.01% 10215
2023
Q3
Sell
-21,924
Closed -$458K 12810
2023
Q2
$458K Sell
21,924
-4,889
-18% -$98.3K ﹤0.01% 8528
2023
Q1
$532K Buy
26,813
+6,752
+34% +$135K ﹤0.01% 8419
2022
Q4
$392K Buy
20,061
+1,340
+7% +$26.4K ﹤0.01% 8435
2022
Q3
$335K Buy
18,721
+1,550
+9% +$30.4K ﹤0.01% 9502
2022
Q2
$326K Buy
+17,171
New +$350K ﹤0.01% 9362

Other funds holding REVS

Jeff Yass's REVS Position: Q2 2026 in Review

Jeff Yass opened a new position in Columbia Research Enhanced Value ETF (REVS) in Q2 2026: 36,736 shares worth $1.15M. The stake represents ﹤0.01% of the portfolio and ranks #7836 among its holdings. This is a return to the name: Jeff Yass previously reported a position in REVS as recently as Q4 2025.

Jeff Yass first reported a position in REVS in Q2 2022 and has held it in 8 quarters since. 38 funds tracked by Wall St. Rank hold REVS as of Q2 2026.

  • Jeff Yass held 36,736 shares of Columbia Research Enhanced Value ETF worth $1.15M as of Q2 2026.
  • Columbia Research Enhanced Value ETF was a new Jeff Yass position in Q2 2026.
  • Columbia Research Enhanced Value ETF made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #7836 holding.
  • Jeff Yass first reported a position in Columbia Research Enhanced Value ETF in Q2 2022 and has held it in 8 quarters since.
  • 38 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.